Comparable to the higher VAF of JAK2 in patients with BCR::ABL1-negative MPN, the higher BCR::ABL1 transcript level might be a risk factor for secondary BCR::ABL1-negative MPN in patients with CML. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.